Aktuelle Webcasts
Vergangene Webcasts
Aktuelle News
News Funktionen
Weitere Funktionen
10 Januar 2013
Proteo Biotech AG
Proteo, Inc. / Proteo Biotech AG: FDA grants Proteo Orphan Drug Designation to Elafin for the treatment of pulmonary arterial hypertension
11 Dezember 2012
Proteo Biotech AG
Proteo, Inc. / Proteo Biotech AG: Update for Phase 2 Study of Elafin in Coronary Bypass Surgery (EMPIRE Study)
27 Juni 2012
Proteo Biotech AG
Proteo, Inc. / Proteo Biotech AG: Further rationale for Elafin treatment in newborn infants – convincing preclinical evidence in a neonatal pulmonary model
22 Juni 2012
Proteo Biotech AG
Proteo, Inc. / Proteo Biotech AG: Update for Phase 2 Study of Elafin in Coronary Bypass Surgery (EMPIRE Study)
6 Dezember 2011
Proteo Biotech AG
Proteo, Inc. / Proteo Biotech AG: Major advances in the elafin development program for lung diseases – NIH supports research on Elafin with a $10.8 million grant
16 August 2011
Proteo Biotech AG
Proteo, Inc. / Proteo Biotech AG: EMPIRE-Studie schließt erste Koronarbypass-Patienten ein
Anstehende Events
Aktuelle Berichte
News Funktionen
Weitere Funktionen
9 November 2012
Proteo Biotech AG
Q3 report 2012
10 August 2012
Proteo Biotech AG
Q2 report 2012
15 Mai 2012
Proteo Biotech AG
Q1 report 2012
28 März 2012
Proteo Biotech AG
Annual Report 2011
7 November 2011
Proteo Biotech AG
Q3 report 2011
4 August 2011
Proteo Biotech AG
Q2 report 2011